NORTHERN TRUST CORP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$33,883,477
-5.2%
2,190,270
-3.7%
0.01%0.0%
Q2 2023$35,742,622
-4.7%
2,275,151
-0.0%
0.01%0.0%
Q1 2023$37,502,498
+1.0%
2,275,637
-4.4%
0.01%
-12.5%
Q4 2022$37,141,323
+30.6%
2,380,854
+8.6%
0.01%
+33.3%
Q3 2022$28,439,000
-10.4%
2,192,587
-3.0%
0.01%
-14.3%
Q2 2022$31,732,000
-0.2%
2,260,119
+1.8%
0.01%
+16.7%
Q1 2022$31,780,000
-0.4%
2,219,358
-5.2%
0.01%
+20.0%
Q4 2021$31,899,000
-13.9%
2,340,337
+3.4%
0.01%
-28.6%
Q3 2021$37,065,000
-48.0%
2,262,834
-46.6%
0.01%
-46.2%
Q2 2021$71,252,000
-14.4%
4,233,682
-7.1%
0.01%
-13.3%
Q1 2021$83,248,000
+4.5%
4,559,026
+4.1%
0.02%
-6.2%
Q4 2020$79,698,000
+5.2%
4,379,029
+3.1%
0.02%
-5.9%
Q3 2020$75,752,000
+10.7%
4,246,187
+11.2%
0.02%
+6.2%
Q2 2020$68,438,000
+32.1%
3,816,937
+11.8%
0.02%
+6.7%
Q1 2020$51,811,000
-29.9%
3,413,112
-8.9%
0.02%
-11.8%
Q4 2019$73,898,000
+9.7%
3,745,454
-4.3%
0.02%
+6.2%
Q3 2019$67,350,000
-6.4%
3,915,673
-3.6%
0.02%
-5.9%
Q2 2019$71,920,000
-16.3%
4,063,308
-3.7%
0.02%
-19.0%
Q1 2019$85,939,000
+49.6%
4,218,850
+23.5%
0.02%
+31.2%
Q4 2018$57,440,0003,414,9990.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders